Population Pharmacokinetics of Hydroxychloroquine in Japanese Patients With Cutaneous or Systemic Lupus Erythematosus

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics

2007 • 739 citations

Revised Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy

2011 • 657 citations

The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): An Outcome Instrument for Cutaneous Lupus Erythematosus

2005 • 450 citations

Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus

2006 • 289 citations

Bioavailability of hydroxychloroquine tablets in healthy volunteers.

1989 • 260 citations

Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice

1997 • 245 citations

Guidelines for referral and management of systemic lupus erythematosus in adults

1999 • 242 citations

Hydroxychloroquine concentration–response relationships in patients with rheumatoid arthritis

2002 • 239 citations

Guidelines for referral and management of systemic lupus erythematosus in adults

1999 • 221 citations

Cutaneous lupus erythematosus: Update of therapeutic options

2010 • 194 citations

Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)

2012 • 189 citations

A dose‐ranging study of the pharmacokinetics of hydroxy‐chloroquine following intravenous administration to healthy volunteers.

1988 • 172 citations

Establishing Best Practices and Guidance in Population Modeling: An Experience With an Internal Population Pharmacokinetic Analysis Guidance

2013 • 167 citations

Pharmacokinetics of Hydroxychloroquine and Its Clinical Implications in Chemoprophylaxis against Malaria Caused by Plasmodium vivax

2009 • 162 citations

Low Blood Concentration of Hydroxychloroquine in Patients With Refractory Cutaneous Lupus Erythematosus

2012 • 138 citations

Dosage of Antimalarial Drugs for Children with Juvenile Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Clinical Study with Determination of Serum Concentrations of Chloroquine and Hydroxychloroquine

1974 • 118 citations

Population Pharmacokinetics of Hydroxychloroquine in Patients With Rheumatoid Arthritis

2003 • 102 citations

The Cutaneous Lupus Erythematosus Disease Area and Severity Index

2008 • 96 citations

Clinical Pharmacokinetics of Slow-Acting Antirheumatic Drugs

1993 • 91 citations

High-performance liquid chromatographic assay for hydroxychloroquine and metabolites in blood and plasma, using a stationary phase of poly(styrene divinylbenzene) and a mobile phase at ph 11, with fluorimetric detection

1985 • 65 citations

Concentration-effect relationship of hydroxychloroquine in rheumatoid arthritis--a cross sectional study.

1993 • 58 citations

Concentration-effect relationship of hydroxychloroquine in patients with rheumatoid arthritis--a prospective, dose ranging study.

2000 • 55 citations

Plasma hydroxychloroquine concentrations and efficacy in rheumatoid arthritis

1987 • 40 citations

Steady-State Pharmacokinetics of Hydroxychloroquine in Rheumatoid Arthritis Patients

1991 • 32 citations

A cross‐sectional study of hydroxychloroquine concentrations and effects in people with systemic lupus erythematosus

2013 • 22 citations

Insights from pharmacokinetic and pharmacodynamic studies of hydroxychloroquine.

1993 • 21 citations

Cited By (0)

Loading...